Adult stem cells restore sight
Treatment aims at total cure, not just symptom relief
A new adult stem cell treatment developed in the UK has restored
sight to several patients in a trial. Researchers at the North East
England Stem Cell Institute regrew the outside membrane of damaged
corneas from stem cells taken from a healthy eye. All of them were
suffering from limbal stem cell deficiency, a painful eye disease that prevents the cornea from renewing itself.
Dr Francisco Figueiredo, who co-led the
project, told the London Telegraph: “Corneal cloudiness has been estimated to cause blindness in
eight million people worldwide each year. The stem cell treatment option is aimed at total cure rather than symptom
relief only. This new treatment will alleviate patient suffering and remove
the need for long term multiple medications as well as returning the patient
to functional and social independence.”
A larger trial with a longer follow-up will be carried out to determine whether
the treatment is reliable, safe and effective in the long term. — London Telegraph, Dec 22; NHS health news, Dec 23
Michael Cook
adult stem cells
stem cells
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...